ALK, ALK receptor tyrosine kinase, 238

N. diseases: 519; N. variants: 41
Source: ALL
Disease Type Disease Class Semantic Type N. genes d N. SNPs d Score gda EL gda EI gda N. PMIDs N. SNPs gda First Ref. Last Ref.
CUI: C0042769
Disease: Virus Diseases
Virus Diseases
group Infections Disease or Syndrome 1471 42 0.010 None 1.000 1 2019 2019
CUI: C0376705
Disease: Viral Load result
Viral Load result
phenotype Finding 65 91 0.100 None 1.000 1 1 2019 2019
CUI: C1861172
Disease: Venous Thromboembolism
Venous Thromboembolism
phenotype Cardiovascular Diseases Disease or Syndrome 378 408 0.020 None 0.500 2 2014 2017
Vasculitis, Leukocytoclastic, Cutaneous
disease Immune System Diseases; Cardiovascular Diseases Disease or Syndrome 18 1 0.010 None 1.000 1 2018 2018
CUI: C0282607
Disease: Vascular Neoplasms
Vascular Neoplasms
group Neoplasms; Cardiovascular Diseases Neoplastic Process 15 0.010 None 1.000 1 2019 2019
CUI: C0042133
Disease: Uterine Fibroids
Uterine Fibroids
group Neoplasms Neoplastic Process 569 154 0.030 None 1.000 3 2016 2020
CUI: C0338113
Disease: Uterine Corpus Sarcoma
Uterine Corpus Sarcoma
disease Neoplasms; Female Urogenital Diseases and Pregnancy Complications Neoplastic Process 30 0.010 None 1.000 1 2019 2019
CUI: C1704376
Disease: Uterine Corpus Carcinosarcoma
Uterine Corpus Carcinosarcoma
disease Neoplastic Process 33 0.010 None 1.000 1 2017 2017
CUI: C0280630
Disease: Uterine Carcinosarcoma
Uterine Carcinosarcoma
disease Neoplasms; Female Urogenital Diseases and Pregnancy Complications Neoplastic Process 41 80 0.010 None 1.000 1 2017 2017
CUI: C2145472
Disease: Urothelial Carcinoma
Urothelial Carcinoma
disease Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases Neoplastic Process 449 10 0.010 None 1.000 1 2014 2014
Urinary Bladder Inflammatory Myofibroblastic Tumor
disease Pathological Conditions, Signs and Symptoms; Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases Neoplastic Process 3 0.020 None 1.000 2 2003 2017
Undifferentiated (Embryonal) Sarcoma
disease Neoplastic Process 35 4 0.010 None 1.000 1 2014 2014
CUI: C2242635
Disease: Tumour thrombosis
Tumour thrombosis
disease Neoplastic Process 19 0.010 None 1.000 1 2018 2018
CUI: C0178874
Disease: Tumor Progression
Tumor Progression
phenotype Pathological Conditions, Signs and Symptoms Neoplastic Process 3865 72 0.090 None 1.000 9 2006 2019
CUI: C2712743
Disease: Tumor lysis syndrome (spontaneous)
Tumor lysis syndrome (spontaneous)
disease Disease or Syndrome 1 0.010 None 1.000 1 2014 2014
CUI: C0598935
Disease: Tumor Initiation
Tumor Initiation
phenotype Pathological Conditions, Signs and Symptoms; Neoplasms Neoplastic Process 533 8 0.010 None 1.000 1 2014 2014
CUI: C1519680
Disease: Tumor Immunity
Tumor Immunity
phenotype Pathological Conditions, Signs and Symptoms Disease or Syndrome 337 2 0.010 None 1.000 1 2018 2018
CUI: C1269955
Disease: Tumor Cell Invasion
Tumor Cell Invasion
phenotype Neoplastic Process 6626 169 0.100 None 1.000 19 2006 2019
CUI: C1519670
Disease: Tumor Angiogenesis
Tumor Angiogenesis
phenotype Pathological Conditions, Signs and Symptoms Neoplastic Process 822 5 0.010 None 1.000 1 2014 2014
CUI: C0795801
Disease: trisomy 2
trisomy 2
disease Pathological Conditions, Signs and Symptoms Disease or Syndrome 8 0.010 None < 0.001 1 2005 2005
CUI: C0040137
Disease: Thyroid Nodule
Thyroid Nodule
disease Neoplasms; Endocrine System Diseases Neoplastic Process 150 17 0.010 None 1.000 1 2019 2019
CUI: C0040136
Disease: Thyroid Neoplasm
Thyroid Neoplasm
disease Neoplasms; Endocrine System Diseases Neoplastic Process 1164 135 0.050 None 1.000 5 2011 2019
CUI: C0549473
Disease: Thyroid carcinoma
Thyroid carcinoma
disease Neoplasms; Endocrine System Diseases Neoplastic Process 1175 145 0.070 None 1.000 7 2011 2019
CUI: C0836924
Disease: Thrombocytosis
Thrombocytosis
disease Hemic and Lymphatic Diseases Disease or Syndrome 93 12 0.010 None 1.000 1 2006 2006
CUI: C0039978
Disease: Thoracic Diseases
Thoracic Diseases
group Respiratory Tract Diseases Disease or Syndrome 5 0.010 None 1.000 1 2019 2019